 | Up a level |
Afshar-Oromieh, A.; Alberts, I.; Sachpekidis, C.; Rominger, A. (2019). [Prostate-specific membrane antigen (PSMA)-based diagnostics and treatment of prostate cancer]. Der Urologe, 58(12), pp. 1429-1434. Springer 10.1007/s00120-019-01067-x
Mercolli, L.; Zeimpekis, K. G.; Bohn, K. P.; Rathke, H. G.; Rominger, A.; Shi, K. (2022). Feasibility study of Y-90 radioembolization post-treatment dosimetry with a long axial field-of-view PET/CT. Nuklearmedizin, 61(02), pp. 158-159. Thieme 10.1055/s-0042-1746003
Imlimthan, S.; Menéndez, E.; Escudero-Castellanos, A.; Moon, E.S.; Läppchen, T.; Rathke, H.; Afshar Oromieh, A.; Röesch, F.; Rominger, A.; Gourni, E. (2022). Preclinical evaluation of a 68Ga-labeled squaric acid-based FAP inhibitor for PET applications. Nuklearmedizin, 61(02), pp. 165-166. Thieme 10.1055/s-0042-1746024
Birindelli, G.; Drobnjakovic, M.; Morath, V.; Alessandria, C.D.; Gourni, E.; Afshar-Oromieh, A.; Weber, W.; Rominger, A.; Eiber, M.; Shi, K. (2022). In silico study on the heterogeneity of the dose distribution and radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapy. Nuklearmedizin, 61(02), pp. 175-176. Thieme 10.1055/s-0042-1746053
